Real-world utilization of andexanet alfa

CS Brown, RA Scott, M Sridharan… - The American Journal of …, 2020 - Elsevier
Objective In 2018, the FDA approved andexanet alfa for the reversal of life-threatening
hemorrhages in patients anticoagulated with apixaban or rivaroxaban. Yet, cost-effective …
被引用次数：47 相关文章

Real-world utilization of andexanet alfa

CS Brown, RA Scott, M Sridharan… - … American journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective In 2018, the FDA approved andexanet alfa for the reversal of life-threatening
hemorrhages in patients anticoagulated with apixaban or rivaroxaban. Yet, cost-effective …

Real-world utilization of andexanet alfa.

CS Brown, RA Scott, M Sridharan… - The American Journal …, 2019 - europepmc.org
Objective In 2018, the FDA approved andexanet alfa for the reversal of life-threatening
hemorrhages in patients anticoagulated with apixaban or rivaroxaban. Yet, cost-effective …

Real-world utilization of andexanet alfa

CS Brown, RA Scott, M Sridharan… - American Journal …, 2020 - mayoclinic.elsevierpure.com
Objective: In 2018, the FDA approved andexanet alfa for the reversal of life-threatening
hemorrhages in patients anticoagulated with apixaban or rivaroxaban. Yet, cost-effective …